肥満と心血管疾患のリスクとの関連性,およびリスクを高める要因
Rodis D Paparodis1, Dimitra Bantouna2, Sarantis Livadas2
1Division of Endocrine Research, Hellenic Endocrine Network, Athens, Greece (Drs Paparodis, Bantouna, Livadas, Angelopoulos); Division of Endocrinology, Diabetes and Metabolism, Edward Hines Jr VA Hospital, Hines, IL, USA (Dr Paparodis); Division of Endocrinology, Diabetes and Metabolism, Loyola University Medical Center, Maywood, IL, USA (Dr Paparodis).
Journal of clinical lipidology
|February 18, 2026
まとめ
肥満は,心血管疾患 (CVD) のリスクおよび関連する要因を大幅に増加させます. ライフスタイルの変更,薬剤,手術を含む効果的な管理戦略は,減量を促進することによって結果を改善します.
科学分野:
- 心臓病学 心臓病学
- エンドクリノロジー エンドクリノロジー
- 公衆衛生は公衆衛生である.
背景:
- 肥満は,世界的に蔓延している流行病です.
- 肥満は,心血管疾患 (CVD) の危険因子やイベントの増加と関連しています.
- CVDは世界中の主要な死因です.
研究 の 目的:
- 肥満とCVDリスクの関係を見直す.
- 肥満とその併発性疾患に対する管理戦略を検証する.
- 肥満とそれによる健康問題の両方に対処する治療法について議論する.
主な方法:
- 国際ガイドラインとメタ分析に関する文献レビュー.
- プロスペクティブ,ランダム化,制御試験,および観察研究を含む.
- 肥満治療法とそのCVDリスクへの影響に関する研究の分析.
主要な成果:
- 肥満は,糖尿病,高血圧,睡眠時無呼吸などの多数のCVDリスク要因と関連しています.
- 減量介入 (ライフスタイル,薬剤,手術) は,CVDの危険因子やイベントを改善します.
- 改善は,体重減少の速度と持続時間と比例しています.
結論:
- CVDの危険因子の管理は,肥満の治療計画において極めて重要です.
- 肥満に対処するには,統合された予防,診断,治療戦略が必要です.
- CVDの発生率とリスク要因を減らすために,個別化された,集団特有のアプローチが必要である.
関連する概念動画
Coronary Artery Disease I: Introduction
1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Psychoneuroimmunology: Cardiovascular Disease
594
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
594
Coronary Artery Disease IV: Preventive Measures
741
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741
Coronary Artery Disease II: Pathophysiology
646
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
646
Overview of Lipid Metabolism
5.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
5.8K


